The national figures for Pakistan for the prevalence of Hepatitus B virus and Hepatitus C virus (HCV) are 2.5 % and 4.9 % respectively . With a population of 200 million, this translates to a healthcare burden of 15 million people suffering from these viruses.
If left untreated, HCV infection results in a condition called cirrhosis, where the liver shrinks in size, and other complications may also occur. It is therefore imperative that hepatitis be treated early and appropriately to prevent these complications from developing.
AKUH provides comprehensive services to patients with hepatitis C and enables access to the latest technology, research and treatment which is being developed with global partners. Together with your assistance, we can continue to provide hepatitis patients with hope.